Bacteriophage P13234mo-mediated intra- and intergroup transduction of antibiotic resistance among streptococci. 1975

H Malke, and R Starke, and W Köhler, and G Kolesnichenko, and A A Totolian

Numerous streptococcal strains representing serogroups A, C, and G were tested for transducibility to antibiotic resistance by the temperate Group A streptococcal phage P13234mo. The resistance markers carried by Group A donor strains included the ERL1 factor determining inducible resistance to erythromycin, lincomycin and streptogramin-B type antibiotics as well as chromosomally located mutations for streptomycin and spectinomycin resistance. ERL1, presumably of plasmid nature, was transduced to each of the 36 Group A strains, 10 of the 16 Group C strains, and 1 of the 10 Group G strains tested. Transduction of streptomycin and spectinomycin resistance occurred at lower frequencies than ERL1 transduction, the percentage of transducible Group A strains was lower for these markers than for ERL1, and intergroup transduction was not observed. The effective in-vitro dissemination of resistance factors such as ERL1 by broad host range phages like P13234mo may have some bearing on the marked increase of the incidence of erythromycin and lincomycin resistant streptococci of several serogroups in clinical specimens.

UI MeSH Term Description Entries
D007612 Kanamycin Antibiotic complex produced by Streptomyces kanamyceticus from Japanese soil. Comprises 3 components: kanamycin A, the major component, and kanamycins B and C, the minor components. Kanamycin A,Kanamycin Sulfate,Kantrex
D008034 Lincomycin An antibiotic produced by Streptomyces lincolnensis var. lincolnensis. It has been used in the treatment of staphylococcal, streptococcal, and Bacteroides fragilis infections. Lincolnensin,Lincomycin, (2S-cis)-Isomer,Epilincomycin,Lincocin,Lincomycin A,Lincomycin Hydrochloride,Lincomycin Monohydrochloride,Lincomycin Monohydrochloride, (2S-cis)-Isomer,Lincomycin Monohydrochloride, (L-threo)-Isomer,Lincomycin Monohydrochloride, Hemihydrate,Lincomycin, (L-threo)-Isomer,Hemihydrate Lincomycin Monohydrochloride
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D004917 Erythromycin A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. Erycette,Erymax,Erythromycin A,Erythromycin C,Erythromycin Lactate,Erythromycin Phosphate,Ilotycin,T-Stat,Lactate, Erythromycin,Phosphate, Erythromycin,T Stat,TStat
D000198 Spectinomycin An antibiotic produced by Streptomyces spectabilis. It is active against gram-negative bacteria and used for the treatment of GONORRHEA. Actinospectacin,Adspec,Ferkel Spectam,Kempi,Prospec,Salmosan-T,Spectam,Spectinomycin Dihydrochloride, Anhydrous,Spectinomycin Dihydrochloride, Pentahydrate,Spectinomycin Hydrochloride,Stanilo,Trobicin,Salmosan T,Spectam, Ferkel
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001435 Bacteriophages Viruses whose hosts are bacterial cells. Phages,Bacteriophage,Phage
D013291 Streptococcus A genus of gram-positive, coccoid bacteria whose organisms occur in pairs or chains. No endospores are produced. Many species exist as commensals or parasites on man or animals with some being highly pathogenic. A few species are saprophytes and occur in the natural environment.
D013307 Streptomycin An antibiotic produced by the soil actinomycete Streptomyces griseus. It acts by inhibiting the initiation and elongation processes during protein synthesis. Estreptomicina CEPA,Estreptomicina Clariana,Estreptomicina Normon,Strepto-Fatol,Strepto-Hefa,Streptomycin Grünenthal,Streptomycin Sulfate,Streptomycin Sulfate (2:3) Salt,Streptomycin Sulphate,Streptomycine Panpharma,Strepto Fatol,Strepto Hefa

Related Publications

H Malke, and R Starke, and W Köhler, and G Kolesnichenko, and A A Totolian
June 2011, Letters in applied microbiology,
H Malke, and R Starke, and W Köhler, and G Kolesnichenko, and A A Totolian
June 1973, The Journal of experimental medicine,
H Malke, and R Starke, and W Köhler, and G Kolesnichenko, and A A Totolian
June 2019, Infection and immunity,
H Malke, and R Starke, and W Köhler, and G Kolesnichenko, and A A Totolian
January 1979, Journal of bacteriology,
H Malke, and R Starke, and W Köhler, and G Kolesnichenko, and A A Totolian
March 1982, Antimicrobial agents and chemotherapy,
H Malke, and R Starke, and W Köhler, and G Kolesnichenko, and A A Totolian
January 1985, Annales de l'Institut Pasteur. Microbiologie,
H Malke, and R Starke, and W Köhler, and G Kolesnichenko, and A A Totolian
August 1973, Journal of bacteriology,
H Malke, and R Starke, and W Köhler, and G Kolesnichenko, and A A Totolian
January 1984, British medical bulletin,
H Malke, and R Starke, and W Köhler, and G Kolesnichenko, and A A Totolian
June 1995, Pediatric clinics of North America,
H Malke, and R Starke, and W Köhler, and G Kolesnichenko, and A A Totolian
April 1972, Indian journal of pathology & bacteriology,
Copied contents to your clipboard!